NEW YORK--(BUSINESS WIRE)-- Press Kit Materials are Available at: http://www.tradeshownews.com/events/BIO-Investor-Forum-2010/ziopharm/
|Event:||BIO Investor Forum 2010
Oct 5 - 6, 2010
San Francisco, CA, US
About Ziopharm Oncology
ZIOPHARM Oncology, Inc. is a biopharmaceutical company that is seeking to develop and commercialize a diverse portfolio of cancer drugs. Our principal focus is on the development of proprietary small molecule drug candidates that work on validated targets. The goal is to develop intravenous ("IV") and/or oral forms of administration. We believe this strategy will result in lower-risk and lower-cost development programs with product candidates having a low cost of manufacturing to address changing reimbursement requirements around the world.
KEYWORDS: United States North America New York
INDUSTRY KEYWORDS: Health Clinical Trials Other Health Research Science